Concepedia
Statistics
Publications
34
Citations
2.5K
H-Index
26
Active since
2003
Affiliations
Bayer (Germany)(Current)
Charité - Universitätsmedizin Berlin
Humboldt-Universität zu Berlin
Bayer (United States)
University of Turku
Arne Scholz is an author at Bayer (Germany) specializing in oncology, medicine, and molecular oncology.
Publications per year
2003–2021
Atu027, a Liposomal Small Interfering RNA Formulation Targeting Protein Kinase N3, Inhibits Cancer Progression
Manuela Aleku, Petra Schulz, Oliver Keil et al. · Cancer Research · 2008 · 295 citations · Full text
Pharmacy, Oncology, Pharmacology +17
Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer
Arne Scholz, Sandra Heinze, Katharina Detjen et al. · Gastroenterology · 2003 · 256 citations · Full text
Life Sciences, Molecular Biology, Oncology +12
Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer
Ulrich Lücking, Arne Scholz, Philip Lienau et al. · ChemMedChem · 2017 · 184 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +14
Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models
Mari I. Suominen, Katja M. Fagerlund, Jukka P. Rissanen et al. · Clinical Cancer Research · 2017 · 176 citations · Full text
Medicine, Oncology, Pharmacology +17
Regorafenib (BAY 73‐4506): Antitumor and antimetastatic activities in preclinical models of colorectal cancer
Roberta Schmieder, Jens Hoffmann, Michael W. Becker et al. · International Journal of Cancer · 2013 · 138 citations · Full text
1–5 of 34